Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 8


Figure 8 Effect of rAAV/ASK{Delta}N(KR) on Dystrophin Degradation and Calpain Activation

(A) Western blot analysis for {alpha}-, ß-, and {gamma}-sarcoglycan (SG) in hamster hearts 14 weeks after gene transfer. (B) Western blot analysis for dystrophin in hamster hearts 14 weeks after gene transfer. Full-length (arrow) and degraded (arrowheads) dystrophin were detected. (C) Western blot analysis for µ- and m-calpain. Arrows indicate autolyzed form of µ-calpain. (D) [Ca2+]i after change to Na+-free solution. (Left panel) Changes in the ratio of fluorescent intensity of fura-2 at 340 nm to that at 380 nm after change to Na+-free solution. A representative averaged recording from at least 3 cardiomyocytes infected with AdV/LacZ or AdV/ASK{Delta}N(KR) is shown. The right panel shows maximum fold changes in the fluorescent intensity ratio of fura-2 (n = 3). (E) Activation of ASK1 induced by Ca2+ overload. ASK1 activity was assessed by immune complex kinase assay with MKK6 as a substrate. (F) Calpain activity during Ca2+ overload. Left panel, changes in the fluorescent intensity of Boc-Leu-Met-CMAC (CMAC) during Ca2+ overload. A representative averaged recording from at least 3 cardiomyocytes is shown. To assess calpain-dependent protease activity, the cells were treated with or without calpeptin, a calpain inhibitor. Right panel shows slopes of CMAC fluorescent intensity curve between 10 and 30 min after change to Na+-free solution (n = 3). *p < 0.05 versus AdV/LacZ-infected cardiomyocytes. Abbreviations as in Figure 1.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement